enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Nortriptyline - Wikipedia

   en.wikipedia.org/wiki/Nortriptyline

   Nortriptyline, sold under the brand name Aventyl, among others, is a tricyclic antidepressant.This medicine is also sometimes used for neuropathic pain, attention deficit hyperactivity disorder (ADHD), smoking cessation and anxiety.

3. 6 Tips for Dealing With Back Pain (Plus Why You May ... - AOL

   www.aol.com/6-tips-dealing-back-pain-115700345.html

   The best treatment for back pain will depend on what’s causing it and how severe the pain is. The good news is most people’s back pain improves in six weeks, and yours may even go away on its own.

4. These Are the Best Medications for Low Back Pain ... - AOL

   www.aol.com/best-medications-low-back-pain...

   For premium support please call: 800-290-4726 more ways to reach us

5. Tricyclic antidepressant - Wikipedia

   en.wikipedia.org/wiki/Tricyclic_antidepressant

   The TCAs are used primarily in the clinical treatment of mood disorders such as major depressive disorder (MDD), dysthymia, and treatment-resistant variants. They are also used in the treatment of a number of other medical disorders, including cyclic vomiting syndrome (CVS) and anxiety disorders such as generalized anxiety disorder (GAD), social phobia (SP) also known as social anxiety ...

6. List of antidepressants - Wikipedia

   en.wikipedia.org/wiki/List_of_antidepressants

   Nortriptyline (Pamelor, Aventyl) Noxiptiline (Agedal, Elronon, Nogedal) Pipofezine (Azafen/Azaphen) Protriptyline (Vivactil) Trimipramine (Surmontil) Opipramol (Insidon), tianeptine (Stablon, Coaxil) and amineptine (discontinued; formerly Survector, Maneon) are chemically TCAs but are pharmacodynamically atypical, and are therefore grouped ...

7. Peripheral neuropathy - Wikipedia

   en.wikipedia.org/wiki/Peripheral_neuropathy

   Cochrane systematically reviewed the evidence for the antidepressants nortriptyline, desipramine, venlafaxine, and milnacipran and in all these cases found scant evidence to support their use for the treatment of neuropathic pain. All reviews were done between 2014 and 2015. [49] [52] [80] [81]